Professional Documents
Culture Documents
Maple Syrup Urine Disease
Maple Syrup Urine Disease
The patient was delivered via lower segment caesarian section in a public sector hospital
that lacks antenatal and intra-partum history that could probably affected the child’s condition.
Only days after his birth, the baby developed lethargy and decreased oral intake on its fifth day
and was rushed to the hospital for 2 days where he was diagnosed with neonatal sepsis, carried
out with broad spectrum of antibiotics for treatment. Upon discharge request, the baby developed
once again recurring reduced oral intake and lethargy constantly. Another diagnosis was brought
up, bringing the baby with hypotonicity behavior and unresponsiveness rate of 3/15 via Glasgow
Coma Score (GCS).
PHYSICAL EXAMINATION:
Age: 46 day old/Male
Weight: 3.0 kg
Length: 48 cm
Occipito-frontal circumference (OFC): 35 cm
Muscle tone: Floppy/Hypotonic
GENETIC ASSESSMENT:
Maple Syrup Urine Disease (MSUD) is a rare, autosomal recessive disorder that is
characterized by branched-chain α-keto-acid dehydrogenase (BCKAD) complex malfunction.
This condition is inherited and may be passed from generation to generation. It is caused by a
defect in 1 out of 3 genes present in the body where it won’t be able to break down amino acids
such as leucine, isoleucine, and valine that can lead to the accumulation of these chemicals in the
blood.
LABORATORY FINDINGS:
Initial laboratory findings revealed a normal complete blood count (CBC), prothrombin
time (PT)/activated partial thromboplastin time (APTT), C-reactive protein (CRP), and blood
glucose levels. His arterial blood gas revealed to be experiencing metabolic acidosis. CSF
examination values were normal for cell count, proteins, and glucose. A workup routine for
inborn error in metabolism was done and initiated, revealing the baby’s plasma lactate to be
slightly increased and plasma ammonia level was found to be 240 μmol/L. Elevated plasma
leucine and isoleucine levels were presented on the plasma amino acid analysis by ion exchange
chromatography performed. CSF was also analyzed through the use of high performance liquid
chromatography which revealed abnormal levels of leucine and isoleucine count, however,
valine was reported to be less than 1.
To be able to prevent worsening the condition, the physician opted to deliver a treatment
to the patient through injecting an oral Thiamine which will help improved the condition of the
baby. Thiamine-response treatment is said to be effective in treating Maple Syrup Urine Disease
since it will provide an intervention on the patients’ diet, maintaining their metabolic condition
normal for a long period of time. Constantly balancing the diet of the patient would most likely
improve their condition since constant sustained balance would provide normal biochemistry and
development. More than a week had passed, the baby’s condition was already improving, and
another Glasgow Coma Scale was performed revealed a result of 12/15 rate which is considered
to be moderate or normal. Counselling was performed to the family regarding the complications
that may arise and the risks of reoccurrence if another pregnancy was made by the family.
REFERENCES:
Centers for Disease Control and Prevention. (2001, August 23). Growth Charts - Data Table of
Infant Head Circumference-for-age Charts. Centers for Disease Control and Prevention.
https://www.cdc.gov/growthcharts/html_charts/hcageinf.htm.
Maple Syrup Urine Disease. NORD (National Organization for Rare Disorders). (2020, June 5).
https://rarediseases.org/rare-diseases/maple-syrup-urine-disease/.
U.S. National Library of Medicine. Maple syrup urine disease: MedlinePlus Medical
Encyclopedia. MedlinePlus. https://medlineplus.gov/ency/article/000373.htm.